Gene therapy restored some light sensitivity in seven of ten blind patients in first optogenetics trial
The treatment uses a single eye injection to make surviving retinal cells respond to amber light, paired with goggles that translate visual scenes into pulses. Six of ten patients hit the threshold for a clinically meaningful improvement.
2 min read